Abattis Bioceuticlas signs LOI with Vertical Design Systems
Under the LOI, Abattis has gained rights to acquire the area of BC to a BioPharma license and the Vertical Design’s equipment. Abattis president and CEO Mike Withrow
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
The tubing assemblies, which consist of molded manifolds and accessories such as filters and connectors, are sterilized using gamma irradiation and manufactured from platinum-cured silicone or AdvantaFlex biopharmaceutical